Prof. Chi-Shuo Chen -- Neubrix™ Exosome Pulmonary Precision Aerosolization Therapy

Model: Neubrix精霧寶

Exhibitor: NATIONAL TSING HUA UNIVERSITY

Booth No: N315A

Characteristic

**Characteristic**
Neubrix™ integrates advanced exosome therapy with intelligent nebulization technology, developing innovative treatment protocols for pulmonary fibrosis patients. The system utilizes umbilical cord mesenchymal stem cell ( ZEN ZEN BIOTECH CO., LTD.) derived exosomes via aerosolization delivery, replacing conventional intravenous injection. Animal studies demonstrate significant improvements in pulmonary function and mortality rates, with histopathological analysis revealing pulmonary fibrosis reversal.
Neubrix™ core technology integrates three patented innovations of the precision nebulization system:
Intelligent Breath-Actuated Technology - Employs acoustic breath-triggered sensing for real-time detection of patient respiratory patterns, precisely controlling nebulization timing
Aerosol Particle Modulation Technology - Utilizes piezoelectric crystal-driven signal modulation to dynamically adjust aerosol particle size distribution, optimizing drug deposition efficiency at respiratory tract lesions
Neural Network Analysis Technology - Integrates data algorithms for personalized dosing parameter adjustment, significantly enhancing drug delivery precision
The system is designed for respiratory physiological characteristics of geriatric and pediatric populations. Our research team independently developed a pocket-sized portable nebulizer, providing safe and effective precision medical solutions for patients requiring long-term respiratory care. Through integration of exosome regenerative medicine and intelligent nebulization technology, this establishes a novel treatment paradigm for pulmonary diseases.

**R & D team/Company Profile**
Precision Nebulization Medical Team
Led by Professor Chen Chih-Shuo from National Tsing Hua University, our precision nebulization medical team integrates academic research, industry experience, and manufacturing expertise, dedicated to innovation in nebulization drug delivery technology and clinical application promotion. Beyond specializing in nebulizer device development, we actively establish strategic partnerships with biotechnology and pharmaceutical industries to expand nebulization therapy applications across diverse disease domains.
Robust Industry Partnerships: Established industry-academia collaboration with Renren Biotech, signed technical cooperation MOU with Tea Research and Extension Station, executed R&D agreements with Herong Biotech and Standard Chem & Pharm, with multiple ongoing partnership negotiations.
Diverse Core Team Expertise:
30-Year Home Respiratory Care Expert - Frontline clinical experience with deep understanding of patient needs and market dynamics
WHO Respiratory Care Consultant - International perspective and regulatory expertise ensuring global standard compliance
Senior Manager from Listed Nebulizer Manufacturer - Extensive manufacturing and operational management experience with precise market trend insights
Clinical Respiratory Therapist - Human clinical trial expertise bridging R&D innovation with medical requirements
Our team combines academic research depth, industry practical experience, and manufacturing technical capabilities, providing comprehensive solutions for the industrialization of precision nebulization medical technology.

**Contact window**
Chen-En Chiang
+886 978199237
paulz60610@gmail.com